Laddar...
Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
In typical hemolytic uremic syndrome (HUS) approximately 25% of patients show central nervous system (CNS) involvement often leading to serious long-term disabilities. We used the C5-complement inhibitor Eculizumab as rescue therapy. From 2011 to 2014, 11 children (median age 22 months, range 11–175...
Sparad:
| I publikationen: | Medicine (Baltimore) |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Wolters Kluwer Health
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4616562/ https://ncbi.nlm.nih.gov/pubmed/26091445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001000 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|